Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Breast cancer screening case-control study design: impact on breast cancer mortality.

Paap E, Verbeek AL, Puliti D, Paci E, Broeders MJ.

Ann Oncol. 2011 Apr;22(4):863-9. doi: 10.1093/annonc/mdq447. Epub 2010 Oct 5.

PMID:
20924073
2.

A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality.

Allgood PC, Warwick J, Warren RM, Day NE, Duffy SW.

Br J Cancer. 2008 Jan 15;98(1):206-9. Epub 2007 Dec 4.

3.

Case-control Studies on the Effectiveness of Breast Cancer Screening: Insights from the UK Age Trial.

van der Waal D, Broeders MJ, Verbeek AL, Duffy SW, Moss SM.

Epidemiology. 2015 Jul;26(4):590-6. doi: 10.1097/EDE.0000000000000285.

PMID:
25767987
4.

A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales.

Fielder HM, Warwick J, Brook D, Gower-Thomas K, Cuzick J, Monypenny I, Duffy SW.

J Med Screen. 2004;11(4):194-8.

PMID:
15563774
5.

Efficacy of mammographic screening of the elderly: a case-referent study in the Nijmegen program in The Netherlands.

van Dijck JA, Holland R, Verbeek AL, Hendriks JH, Mravunac M.

J Natl Cancer Inst. 1994 Jun 15;86(12):934-8.

PMID:
8196083
6.

Minor influence of self-selection bias on the effectiveness of breast cancer screening in case-control studies in the Netherlands.

Paap E, Verbeek A, Puliti D, Broeders M, Paci E.

J Med Screen. 2011;18(3):142-6. doi: 10.1258/jms.2011.011027.

PMID:
22045823
7.

Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.

de Koning HJ, Boer R, Warmerdam PG, Beemsterboer PM, van der Maas PJ.

J Natl Cancer Inst. 1995 Aug 16;87(16):1217-23.

PMID:
7563167
8.

Increasingly strong reduction in breast cancer mortality due to screening.

van Schoor G, Moss SM, Otten JD, Donders R, Paap E, den Heeten GJ, Holland R, Broeders MJ, Verbeek AL.

Br J Cancer. 2011 Mar 15;104(6):910-4. doi: 10.1038/bjc.2011.44. Epub 2011 Feb 22.

9.

The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies.

Broeders M, Moss S, Nyström L, Njor S, Jonsson H, Paap E, Massat N, Duffy S, Lynge E, Paci E; EUROSCREEN Working Group.

J Med Screen. 2012;19 Suppl 1:14-25. Review.

PMID:
22972807
10.

Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction.

Puliti D, Miccinesi G, Collina N, De Lisi V, Federico M, Ferretti S, Finarelli AC, Foca F, Mangone L, Naldoni C, Petrella M, Ponti A, Segnan N, Sigona A, Zarcone M, Zorzi M, Zappa M, Paci E; IMPACT Working Group.

Br J Cancer. 2008 Aug 5;99(3):423-7. doi: 10.1038/sj.bjc.6604532. Erratum in: Br J Cancer. 2008 Nov 18;99(10):1756.

11.

Impact of Screening on Breast Cancer Mortality: The UK Program 20 Years On.

Massat NJ, Dibden A, Parmar D, Cuzick J, Sasieni PD, Duffy SW.

Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):455-62. doi: 10.1158/1055-9965.EPI-15-0803. Epub 2015 Dec 8.

12.

Mammographic screening and breast cancer mortality: a case-control study and meta-analysis.

Nickson C, Mason KE, English DR, Kavanagh AM.

Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1479-88. doi: 10.1158/1055-9965.EPI-12-0468.

13.

Breast cancer screening: are we seeing the benefit?

Puliti D, Zappa M.

BMC Med. 2012 Sep 20;10:106.

14.

Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2007;7(1):1-32. Epub 2007 Jan 1.

15.

Breast cancer mortality after screening mammography in British Columbia women.

Coldman A, Phillips N, Warren L, Kan L.

Int J Cancer. 2007 Mar 1;120(5):1076-80.

16.

A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer.

Moss SM, Summerley ME, Thomas BT, Ellman R, Chamberlain JO.

J Epidemiol Community Health. 1992 Aug;46(4):362-4.

17.

Impact of deprivation on breast cancer survival among women eligible for mammographic screening in the West Midlands (UK) and New South Wales (Australia): Women diagnosed 1997-2006.

Woods LM, Rachet B, O'Connell D, Lawrence G, Coleman MP.

Int J Cancer. 2016 May 15;138(10):2396-403. doi: 10.1002/ijc.29983. Epub 2016 Feb 13.

18.

Further evidence of benefits of a (non-randomised) breast cancer screening programme: the DOM project.

Collette HJ, de Waard F, Rombach JJ, Collette C, Day NE.

J Epidemiol Community Health. 1992 Aug;46(4):382-6.

19.
20.

[The effectiveness of population-based breast cancer screening programme].

Szynglarewicz B, Matkowski R, Kasprzak P, Kotowska J, Forgacz J, Pudełko M, Kornafel J.

Pol Merkur Lekarski. 2009 Feb;26(152):117-20. Polish.

PMID:
19388515

Supplemental Content

Support Center